Hyo Won Chang

893 total citations
33 papers, 732 citations indexed

About

Hyo Won Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hyo Won Chang has authored 33 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Hyo Won Chang's work include Cancer-related Molecular Pathways (10 papers), Autophagy in Disease and Therapy (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Hyo Won Chang is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Autophagy in Disease and Therapy (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Hyo Won Chang collaborates with scholars based in South Korea, United States and Puerto Rico. Hyo Won Chang's co-authors include Sang Yoon Kim, Seong Who Kim, Hae Yun Nam, Myung Woul Han, Jong‐Lyel Roh, Jong Cheol Lee, Youngro Byun, Kyung‐Ja Cho, Soon Yuhl Nam and Sang Yoon Kim and has published in prestigious journals such as Biomaterials, Cancer Research and Oncogene.

In The Last Decade

Hyo Won Chang

32 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyo Won Chang South Korea 16 477 222 183 142 68 33 732
Jinxiang Tan China 14 429 0.9× 253 1.1× 208 1.1× 64 0.5× 81 1.2× 21 818
Sahithi Pamarthy United States 19 481 1.0× 131 0.6× 227 1.2× 87 0.6× 153 2.3× 23 830
Shaojiang Zheng China 15 626 1.3× 299 1.3× 211 1.2× 130 0.9× 158 2.3× 52 1.1k
Chang‐Ying Guo China 10 527 1.1× 396 1.8× 155 0.8× 108 0.8× 79 1.2× 23 769
Junhye Kwon South Korea 18 594 1.2× 205 0.9× 274 1.5× 44 0.3× 93 1.4× 31 854
Navneet Momi United States 13 522 1.1× 191 0.9× 408 2.2× 87 0.6× 50 0.7× 19 854
Xiuling Li China 16 380 0.8× 198 0.9× 207 1.1× 120 0.8× 40 0.6× 46 788
Verena Köberle Germany 15 546 1.1× 443 2.0× 82 0.4× 194 1.4× 33 0.5× 19 898
Masaaki Miyo Japan 17 482 1.0× 275 1.2× 421 2.3× 100 0.7× 119 1.8× 56 967

Countries citing papers authored by Hyo Won Chang

Since Specialization
Citations

This map shows the geographic impact of Hyo Won Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyo Won Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyo Won Chang more than expected).

Fields of papers citing papers by Hyo Won Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyo Won Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyo Won Chang. The network helps show where Hyo Won Chang may publish in the future.

Co-authorship network of co-authors of Hyo Won Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Hyo Won Chang. A scholar is included among the top collaborators of Hyo Won Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyo Won Chang. Hyo Won Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nam, Hae Yun, Seung‐Ho Park, Eun‐Young Kim, et al.. (2024). TIGAR coordinates senescence-associated secretory phenotype via lysosome repositioning and α-tubulin deacetylation. Experimental & Molecular Medicine. 56(12). 2726–2738. 2 indexed citations
2.
Cho, Young Seok, Seung Woo Chung, Hyo Won Chang, et al.. (2022). Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer. Journal of Controlled Release. 344. 26–38. 14 indexed citations
3.
Kim, Hyo‐Suk, Hyun‐Ju Park, Hyo Won Chang, et al.. (2022). Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer. Bioactive Materials. 25. 527–540. 42 indexed citations
4.
Lee, Jong Cheol, Na Kyeong Lee, Seong Who Kim, et al.. (2022). Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG. Journal of Controlled Release. 346. 158–168. 11 indexed citations
5.
Park, Jung Je, Young‐Sool Hah, Jong Sil Lee, et al.. (2021). MDM2-dependent Sirt1 degradation is a prerequisite for Sirt6-mediated cell death in head and neck cancers. Experimental & Molecular Medicine. 53(3). 422–431. 8 indexed citations
6.
Chang, Hyo Won, Yoon Sun Lee, Song Hee Kim, et al.. (2020). p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells. Cellular Signalling. 77. 109820–109820. 13 indexed citations
7.
Chang, Hyo Won, Mi Ra Kim, Yoon Sun Lee, et al.. (2019). p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer. Oncogene. 38(19). 3729–3742. 40 indexed citations
8.
Han, Myung Woul, In Sun Ryu, Jong Cheol Lee, et al.. (2018). Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer. Oral Oncology. 78. 56–63. 24 indexed citations
9.
Chung, Seung Woo, Seho Kweon, Jeong Uk Choi, et al.. (2018). Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment. Biomaterials. 182. 35–43. 23 indexed citations
10.
Kim, Song Hee, Seong Who Kim, Jong Cheol Lee, et al.. (2018). EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition. Cellular Signalling. 47. 122–130. 12 indexed citations
11.
Lee, Myungjin, et al.. (2016). Radiotherapy-associated Furin Expression and Tumor Invasiveness in Recurrent Laryngeal Cancer. Anticancer Research. 36(10). 5117–5126. 15 indexed citations
12.
Han, Myung Woul, Jong Cheol Lee, Junyoung Choi, et al.. (2014). Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation.. PubMed. 34(3). 1449–55. 41 indexed citations
13.
Lee, Jong Cheol, Young Joo Min, Hee Jeong, et al.. (2014). Development of TRAIL Resistance by Radiation-Induced Hypermethylation of DR4 CpG Island in Recurrent Laryngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 88(5). 1203–1211. 13 indexed citations
14.
Nam, Hae Yun, Myung Woul Han, Hyo Won Chang, et al.. (2013). Radioresistant Cancer Cells Can Be Conditioned to Enter Senescence by mTOR Inhibition. Cancer Research. 73(14). 4267–4277. 53 indexed citations
15.
Nam, Hae Yun, et al.. (2013). Prolonged autophagy by MTOR inhibitor leads radioresistant cancer cells into senescence. Autophagy. 9(10). 1631–1632. 45 indexed citations
16.
Kim, Mi Ra, Hyo Won Chang, Hae Yun Nam, et al.. (2012). Activation of p53–p21 is closely associated with the acquisition of resistance to apoptosis caused by β1-integrin silencing in head and neck cancer cells. Biochemical and Biophysical Research Communications. 418(2). 260–266. 3 indexed citations
17.
Chang, Hyo Won, Yoon Se Lee, Hae Yun Nam, et al.. (2012). Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cellular Signalling. 25(4). 839–847. 53 indexed citations
18.
Moon, So Young, Hyo Won Chang, Jong‐Lyel Roh, et al.. (2009). Using YC-1 to overcome the radioresistance of hypoxic cancer cells. Oral Oncology. 45(10). 915–919. 28 indexed citations
19.
Chang, Hyo Won, et al.. (2007). Wnt signaling controls radiosensitivity via cyclooxygenase‐2‐mediated Ku expression in head and neck cancer. International Journal of Cancer. 122(1). 100–107. 55 indexed citations
20.
Chang, Hyo Won, Sang Yoon Kim, Jong Hoon Kim, et al.. (2006). Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck. Oral Oncology. 42(10). 979–986. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026